Genotwin Overview

  • Founded
  • 2020

Founded
  • Status
  • Private

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Genotwin General Information

Description

Developer of a genomics platform designed to transform the diagnosis, surveillance, and treatment of pathogens. The company's platform realizes the epidemiologic analysis of infectious diseases and precision anti-cancer medicine by using genome big data analysis technology, enabling clinicians to address and control the emergence of novel pathogens at an early stage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • 38 Clarence Avenue
  • Bridgewater, MA 02324
  • United States
+1 (347) 000-0000

Genotwin Timeline

20212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genotwin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Dec-2021 00000 Completed Startup
1. Angel (individual) 15-Dec-2020 00000 00000 Completed Startup
To view Genotwin’s complete valuation and funding history, request access »

Genotwin Executive Team (7)

Name Title Board Seat Contact Info
Connor Dowling Chief Executive Officer
Reuben Danzing Chief Financial Officer, Director of Strategy and Business Planning Executive
Oliver Elliott Co-Founder & Chief Technology Officer
Do-Hyun Nam Ph.D Co-Founder & Advisor
Raul Rabadan Ph.D Co-Founder & Chief Science Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Genotwin Board Members (1)

Name Representing Role Since
Seunghee Ham Genotwin Co-Founder & Board Member 000 0000
To view Genotwin’s complete board members history, request access »

Genotwin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genotwin Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mint Venture Partners (Seoul) Accelerator/Incubator Minority 000 0000 000000 0
To view Genotwin’s complete investors history, request access »